Prurigo: Clinical Trials

2 trials for Prurigo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 32Completed 2

Follow Prurigo: new trials by email Literature Review of Prurigo trials Research Report on Prurigo

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis
nalbuphine HCl ER - Prurigo Nodularis, Nodularis Prurigo
Phase 2 / Phase 3CompletedTrevi Therapeutics362015-08-152025-05-21
Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis
nalbuphine HCl ER tablets 90 mg BID, nalbuphine HCl ER tablets 180 mg BID, Placebo tablets BID - Prurigo Nodularis, Nodularis Prurigo
Phase 2 / Phase 3CompletedTrevi Therapeutics622015-03-012025-05-21

Narrower conditions

Pruritus (2)

Broader conditions

Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Skin Diseases (2)  ·  Skin Manifestations (2)  ·  Skin and Connective Tissue Diseases (2)

Interventions

BID protein, human (1)  ·  Nalbuphine (1)  ·  Sugars (1)

Sponsors

Trevi Therapeutics (2)

Countries

Germany (2)  ·  Poland (1)  ·  United States (1)

Results publications

PMID 34780095, PMID 34908192, PMID 36680419